08.02.19
NutriScience Innovations and Arjuna Natural have introduced a high potency ashwagandha extract branded as Shoden, available as a powder standardized to 35% withanolide glycosides, with a recommended dose of 120 mg.
Shoden has been studied in three completed clinical trials; two more are in progress. Significant increases in testosterone in men, reductions in cortisol levels, and improvements in non-restorative sleep have been demonstrated in the trials. Ongoing trials are related to endurance and immune support. Shoden has a full spectrum of known and newly identified withanolide glycoside bioflavonoids as analyzed by HPLC (High Pressure Liquid Chromatography) and other methods. Bioavailability studies show that Shoden withanolides remain in the blood even at 24 hours.
The market for ashwagandha is exploding and Shoden is being introduced at an ideal time to meet strong consumer demand for this Ayurvedic herb. Shoden combines Indian Ayurvedic tradition with modern science. Shoden is developed and manufactured by Arjuna and is now available in North America exclusively from NutriScience.
“Arjuna has used its product development, manufacturing, and scientific expertise to develop this new standardized extract,” said Benny Antony, PhD, managing director at Arjuna. “Arjuna is working on multiple aspects of Shoden—the clinical and scientific studies, new analytical developments, and GMP manufacturing.”
Michael Lelah, PhD, chief science officer at NutriScience, said “Shoden has all the pieces for a prized dietary ingredient—low dose, demonstrated potency, full spectrum analysis, high manufacturing quality, no safety or regulatory concerns, patented, clean label. Easy for formulating in a standalone product or in combination with other ingredients for a wide spectrum of product claims.”
Alan Yengoyan, CEO at NutriScience said: “I am very excited to partner with Arjuna on Shoden. Both companies share the same vision of bringing new innovations backed by science, like Shoden, to the benefit of consumers and the customers we serve.”
Shoden has been studied in three completed clinical trials; two more are in progress. Significant increases in testosterone in men, reductions in cortisol levels, and improvements in non-restorative sleep have been demonstrated in the trials. Ongoing trials are related to endurance and immune support. Shoden has a full spectrum of known and newly identified withanolide glycoside bioflavonoids as analyzed by HPLC (High Pressure Liquid Chromatography) and other methods. Bioavailability studies show that Shoden withanolides remain in the blood even at 24 hours.
The market for ashwagandha is exploding and Shoden is being introduced at an ideal time to meet strong consumer demand for this Ayurvedic herb. Shoden combines Indian Ayurvedic tradition with modern science. Shoden is developed and manufactured by Arjuna and is now available in North America exclusively from NutriScience.
“Arjuna has used its product development, manufacturing, and scientific expertise to develop this new standardized extract,” said Benny Antony, PhD, managing director at Arjuna. “Arjuna is working on multiple aspects of Shoden—the clinical and scientific studies, new analytical developments, and GMP manufacturing.”
Michael Lelah, PhD, chief science officer at NutriScience, said “Shoden has all the pieces for a prized dietary ingredient—low dose, demonstrated potency, full spectrum analysis, high manufacturing quality, no safety or regulatory concerns, patented, clean label. Easy for formulating in a standalone product or in combination with other ingredients for a wide spectrum of product claims.”
Alan Yengoyan, CEO at NutriScience said: “I am very excited to partner with Arjuna on Shoden. Both companies share the same vision of bringing new innovations backed by science, like Shoden, to the benefit of consumers and the customers we serve.”
